ideas45229 님의 블로그

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on the horizon, including contributions from Asian developers like Japan's Sumitomo Pharma. With high levels of unmet need, particularly in NPM1-mutant and KMT2A-rearranged AML, this class is expected to play a critical role in the next g..

The cystinosis therapeutic landscape continues to evolve gradually, although it remains largely dominated by long-established cysteamine-based treatments that have been the cornerstone of disease management for decades. These therapies, while effective in reducing cystine accumulation and improving survival outcomes, fall short of delivering curative or fully disease-modifying benefits. As a res..

Over the past decade, cell-based immunotherapy has emerged as one of the most promising approaches in oncology, particularly for the treatment of solid tumors. Among these innovations, tumor-infiltrating lymphocyte (TIL) therapy has gained considerable traction due to its personalized mechanism and ability to harness the patient's own immune system. Companies such as Iovance Biotherapeutics, Obs..

The market for myopia treatment devices is witnessing notable momentum, largely supported by the rising incidence of myopia and high myopia worldwide. Continuous advancements in vision correction technologies, increasing awareness regarding early diagnosis and preventive eye care, and the strong focus on product innovation by major industry players are further strengthening market growth. The gr..